Mefuparib (CVL218) is a poly ADP-ribose polymerase ( PARP ) inhibitor used in cancer research that exhibits potent brain penetration due to its high protein binding.
References:
[1]. Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats
References:
[1]. Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1/2 inhibitor, in rats
















